Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Biosimilars: Opportunities and Challenges

As the demand for affordable, effective treatments grows, biosimilars offer promising solutions in healthcare. Explore the potential, challenges, and regulatory landscape shaping this expanding market
  • GxP
Biosimilars are biologic medicines that are highly similar to an existing FDA-approved biologic, known as the “reference product.”

Contamination Control Strategy: A Guide to Creating an Effective Plan

A robust contamination control strategy is vital in regulated industries to maintain safety and compliance. Discover key components, documentation practices, and best strategies to reduce contamination risks.
  • GMP, Quality Management System
A contamination control strategy serves as a foundational plan for maintaining a clean environment

Patient-Centric Approaches in Clinical Trials

Clinical trials are undergoing a transformative shift, with a growing focus on patient-centric approaches. This change prioritizes patient needs and convenience by integrating digital health solutions, making trials more accessible, efficient, and aligned with today’s healthcare landscape.
  • Quality Management System
Remote monitoring technologies enhance patient-centric trials by enabling real-time data collection from patients at home, improving convenience and data quality.

AI in Drug Development: Transforming the Future of Medicine

Artificial Intelligence (AI) is reshaping the pharmaceutical industry, optimizing drug discovery, clinical trials, and personalized medicine. Learn how AI is accelerating the drug development process and improving patient outcomes.
  • Quality Management System
AI and machine learning are being applied specifically to drug discovery, showcasing some real-world examples and the potential future impact on healthcare.

EU GMP Annex 1: Your Guide to Contamination Control

Explore the essential distinctions that exist between the previous version and the most recent updates of the EU GMP Annex 1 guidelines. Understand how these changes play a critical role in shaping the practices of sterile pharmaceutical manufacturing. Additionally, examine
  • GMP, GxP
The revised EU GMP Annex 1 modernizes sterile manufacturing with technology and a risk-based approach, improving product quality and patient safety.

Tips for Validation Documentation in Regulatory Audits

Learn key best practices for developing thorough validation documentation to enhance the effectiveness of regulatory audits. Following these practices will help ensure your processes comply with industry standards, boosting both credibility and operational integrity.
  • Process Validation, Validation and Qualification
The success of your regulatory audit largely depends on how well-prepared and detailed your validation documentation is

URS: Compliance, Quality, and Efficiency in Pharma

Learn how to draft comprehensive URS documents for pharmaceutical equipment like HPLC, weighing balances, and HVAC systems to ensure compliance and operational efficiency.
  • Equipment Qualification, Validation and Qualification
A good URS guarantees pharmaceutical equipment meets user needs and regulatory standards.

Validation Master Plans (VMP) in Equipment Qualification

A Validation Master Plan (VMP) is essential for pharmaceutical equipment qualification, serving as a roadmap for validation activities. This guide outlines the VMP process, necessary documentation, and steps for creating an effective VMP to ensure regulatory compliance.
  • Equipment Qualification, Validation and Qualification
A Validation Master Plan (VMP) details the strategy for validating pharmaceutical manufacturing processes and equipment.

Design Qualification: Steps for Effective Implementation

Design Qualification (DQ) is a critical step in the pharmaceutical industry's equipment qualification process. This stage ensures that equipment meets regulatory and operational requirements before installation and production. Learn about the DQ process, necessary documentation, and challenges in achieving compliance.
  • Equipment Qualification, Validation and Qualification
The Design Qualification (DQ) process involves several key steps to ensure that equipment is suitable for its intended use

FAT and SAT in the Pharmaceutical Industry: Key Elements of Equipment Qualification

In the pharmaceutical industry, Factory Acceptance Testing (FAT) and Site Acceptance Testing (SAT) are crucial steps in equipment qualification. These processes ensure that equipment meets all regulatory requirements and functions as expected, both at the manufacturer’s site and after installation.
  • Equipment Qualification, Validation and Qualification
Two critical aspects of this qualification are Factory Acceptance Testing (FAT) and Site Acceptance Testing (SAT). FAT and SAT